
RLMD
USDRelmada Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$2.210
고가
$2.810
저가
$2.190
거래량
0.98M
기업 기본 정보
시가총액
91.9M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.74M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized
관련 주식
IIF
Morgan Stanley India Investment Fund Inc.
SOHON
Sotherly Hotels Inc. 8.25% Series D Cumulative Redeemable Perpetual Preferred Stock
CSGS
CSG Systems International Inc.
GH
Guardant Health Inc.
FIZZ
National Beverage Corp.
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기